drugset / Trial / NCT02578030
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To provide additional, required information on the pharmacokinetic profile of SHP465 in the targeted population (children and adolescents aged 6-17 years of age with ADHD).
Timeline
- Start
- 2015-10-24
- Primary completion
- 2015-11-10
- Completion
- 2015-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHP465 | Unknown | 12.5 mg | — |
| Subject | SHP465 | Unknown | 25 mg | — |